Nurse Practitioner, Family · Garland, TX
NPI
1720587082
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
7217 Telecom Pkwy Ste 300
Garland, TX, 75044
Phone (469) 800-2010
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
279 services
Medicare patients, 2024
148
Average age 71
Drug cost, 2024
$788K
1,258 prescriptions
Company payments, 2025
$1,514
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Massoud Rasooli was code 99214 (office e&m - established), 94 times for 65 patients. In total Massoud Rasooli billed 279 services in 8 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 94 | 65 | $79.42 | $7,465 |
| 99232 Hospital E&M - Subsequent | Facility | 72 | 33 | $51.95 | $3,740 |
| 99203 Office E&M - New | Office | 53 | 53 | $57.75 | $3,061 |
| 99222 Hospital E&M - Initial | Facility | 43 | 39 | $86.01 | $3,699 |
| 99204 Office E&M - New | Office | 12 | 12 | $102.36 | $1,228 |
By year: 2022 $23K for 306 services; 2023 $22K for 296 services; 2024 $20K for 279 services.
Medicare prescription drug claims, 2024
In 2024, the drug Massoud Rasooli prescribed most often to Medicare patients was Pantoprazole Sodium, with 173 prescriptions and refills. In total Massoud Rasooli wrote 1,258 Medicare prescriptions that cost $788K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 173 | 408 | 87 | $1,122 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 171 | 171 | 155 | $2,677 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 113 | 113 | 100 | $1,700 |
| Omeprazole Generic | 95 | 257 | 39 | $1,636 |
| Sucralfate Generic | 82 | 89 | 42 | $1,458 |
| Linzess Linaclotide | 79 | 149 | 28 | $80K |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 78 | 78 | 77 | $13K |
| Famotidine Generic | 61 | 119 | 26 | $932 |
| Dicyclomine Hcl Generic | 52 | 53 | 29 | $353 |
| Zenpep Lipase/Protease/Amylase | 33 | 53 | 11 | $237K |
| Creon Lipase/Protease/Amylase | 32 | 62 | 14 | $141K |
| Hydrocortisone Generic | 26 | 26 | 17 | $361 |
| Cholestyramine Cholestyramine (With Sugar) | 23 | 24 | 16 | $1,592 |
| Lactulose Generic | 19 | 25 | Under 11 | $582 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 19 | 19 | 16 | $236 |
Brand drugs: 446 claims; generic drugs: 812 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Massoud Rasooli $1,514 ($1,514 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $575.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 38 | $575 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 18 | $320 |
| Ardelyx, Inc. ARDX | 10 | $230 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $66.11 |
| Genzyme Corporation SNY | 2 | $59.74 |
| RedHill Biopharma Inc. RDHL | 2 | $48.6 |
| Madrigal Pharmaceuticals MDGL | 2 | $47.25 |
| Braintree Laboratories, Inc. | 1 | $37.79 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $32.76 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $24.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.